跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
RAMIPRIL
Authorized
STANDARD
RAMIPRIL
altamed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
db1036aa72538969
Company
altamed pharma
Type
Standard
Approval Details
Approval Id
db1036aa72538969
Drug Approval Canada Name
RAMIPRIL
Product Name
RAMIPRIL
Status
Cancelled Post Market
Status Date
2022-06-13
Original Market Date
2020-02-25
Din
02486520
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.04
Atc Original
C09AA05 RAMIPRIL
Atc Name
c 09 aa 05
Aig Number
0122858003
Company Name
altamed pharma
Company Address
151 Boulevard De Mortagne, Boucherville, Quebec, Canada, J4B 6G4
Active Ingredients
RAMIPRIL
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
db1036aa72538969
Type
Standard
Back to Health Canada Approvals
RAMIPRIL - Health Canada Drug Approval Details